Manolo: That was a pretty good email you got back
Post# of 30025
Can you post the email you sent him, so I can see how you set him up? You got him to acknowledge that wolframs would require a "regenerative therapy" and he obviously knew you were referring to recombinant MANF.
You know, AMBS is paying him to do research on our recombinant MANF and so his reluctance to mention it in any of his blogs may be due to an NDA. But you managed to get a little bit of info from him that was very assuring.
This was a nice way to end Thanksgiving!